 | Up a level |
Koschut, David and Ray, Debleena and Li, Zhenhua and Giarin, Emanuela and Groet, Jurgen and Alic, Ivan and Kham, Shirley Kow-Yin and Chng, Wee Joo and Ariffin, Hany Mohd and Weinstock, David M. and Yeoh, Allen Eng-Juh and Basso, Giuseppe and Nizetic, Dean (2021) RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia. Oncogene, 40 (4). pp. 746-762. ISSN 0950-9232, DOI https://doi.org/10.1038/s41388-020-01567-7.
